Main > ONCOLOGY (**) > Breast Cancer>HER2+>Adjuvant *** > USA. P. Neratinib Maleate Tab.>

---

USA. P. Neratinib Maleate Tab.>'s subsections
(*) AR Approval Date: ?
(*) CN Approval Date: 2020. 05.07
(*) EU Approval Date: 2018. 09.04
(*) HK Approval Date: 2019
(*) USA Approval Date: 2017. 07.17
(*) USA Launch Date: 2017. 07.31
>Adjuvant TrastuzuMAb Therapy
Company
Company Licensee (CN; HK; TW)
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 9
Patent>UpDate: 2020. 01.07.
TradeMark
TradeMark Web-Site
Tyrosine KInase Inhibitor

USA. P. Neratinib Maleate Tab.>'s products
This section has no products